Medulloblastoma. Period of risk reviewed
- 1 January 1985
Abstract
Collins postulated that patients with Wilms' tumor surviving for a period equal to their age at diagnosis plus 9 months were no longer at risk for a recurrence. Although this no longer holds for Wilms' tumor, it has been applied to patients with medulloblastoma. Case histories of patients who survived a period of risk designated by Collins' rule and later developed a histologically confirmed recurrent medulloblastoma are discussed. Reported cases violating Collins' rule constitute less than 2% of all medulloblastomas. The continued use of Collins' rule is advocated. Patients who have survived this period of risk, are neurologically stable, and have a negative computerized tomography (CT) head scan are exceedingly unlikely to develop a recurrent medulloblastoma.This publication has 18 references indexed in Scilit:
- Medulloblastoma, thyroid carcinoma, and recurrent brain tumor in the same patientMedical and Pediatric Oncology, 1982
- Radiation treatment for medulloblastomaJournal of Neurosurgery, 1981
- Glioblastoma Multiforme Occurring 13 Years after Treatment of a MedulloblastomaNeurosurgery, 1980
- Medulloblastoma.Treatment results and effect on normal tissuesCancer, 1979
- Development of cerebellar malignant astrocytoma at site of a medulloblastoma treated 11 years earlierJournal of Neurosurgery, 1978
- Period of risk for recurrence in medulloblastomaJournal of Neurosurgery, 1978
- Medulloblastoma in children: A correlation between staging and results of treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Medulloblastoma in childrenJournal of Neurosurgery, 1977
- RADIATION THERAPY IN THE MANAGEMENT OF BRAIN TUMORS IN CHILDRENAnnals of the New York Academy of Sciences, 1969
- Medulloblastoma—a review of prognosis and survivalThe British Journal of Radiology, 1969